during her first pregnancy she had experienced worsen ing of her migraines with attacks every 2-3 weeks. Ul trasonography studies of the fetus showed no abnormali ties, and there was no evidence of HELLP syndrome in the patient's serum. The patient was also seen by neurol ogy and ophthalmology, and migraine attack with cluster headache was diagnosed. To exclude a vascular pathol ogy as the cause of her symptoms, standard cranial MRI (without contrast agent; T1-and T2-weighted and time-offlight angiography) was performed. A left-sided lesion (53 × 66 mm, 53.1 cm 3 ) with local mass effect and perifocal edema was detected and suspicious for a lateral sphenoid wing meningioma (Fig. 1) . After the tentative diagnosis, an uneventful cesarean section was performed because of a term unborn (no retardation in growth or organ forma tion) in ultrasonography diagnostics. Delivery was fol lowed by Gdenhanced MRI, which showed homogeneous enhancement of contrast agent, reinforcing the suspected diagnosis.
Postpartum, the patient still demonstrated no neurologi cal deficit and no evidence of epileptic seizures under lowdose steroid therapy; thus, the resection was postponed for elective surgery 2 months after delivery. Magnetic reso nance imaging was repeated before the scheduled surgery, revealing significant mass reduction (50%) of the initial tumor (30 × 35 mm, 27.6 cm 3 ; Fig. 1 ). Options were dis cussed with the patient.
Operation
Microsurgical resection was uneventfully performed via a left frontotemporal craniotomy without complica tions. A complete resection could be achieved by excising the basal dura mater and drilling the hyperostotic areas of the lateral sphenoid with a highspeed bur.
Postoperative Course
Except for a single epileptic seizure 1 day after surgery, the patient's course was uneventful. Anticonvulsive treat ment was administered for 3 months, so breastfeeding had to be discontinued. Postoperative imaging showed com plete resection of the tumor.
Histopathological Workup
Histopathological workup was performed using ready touse antibodies against the estrogen receptor and the progesterone receptor (both Ventana). It revealed the diag nosis of a microcystic meningioma (WHO Grade I) with progesterone receptor expression over 90% (Fig. 2) . The tumor showed no expression of the estrogen receptor.
discussion
In WHO Grade I meningiomas a slow growth pattern is usually observed. While there are wellknown relations between proliferation and tumor grade, 20, 21 different pat terns of behavior for intracranial meningiomas under the influence of elevated serum levels of sex hormones (for ex ample, progesterone) during pregnancy have also been re ported; tumor growth 9 and neurological improvement due to possible minimal regression 4 have both been observed. Clear volumetric tumor regression after pregnancy has not been documented. Given the meningioma's expression of different hormone receptors for progesterone, androgen, estrogen, and placenta growth factor 2,10,11 and its response to increased serum levels of sex hormones during preg nancy, rapid tumor growth or the sudden onset of symp toms (for example, headache, double vision), as occurred in the presented case, seems plausible. This may also ex plain why symptoms might develop for the first time dur ing the course of a pregnancy. After delivery significant reduction of the tumor was observed, most likely because it lacked stimulation by a decreased serum progesterone level. The high level of progesterone receptor expression of more than 90% in the specimen is particularly note worthy given the numerous studies investigating the role of sex hormones and the overabundance of such tumors in women. 1, 8, 28, 31 A small cohort study 23 revealed a correlation between progesterone receptor status and the biological behavior of tumors; patients with progesteronepositive tumors showed decreased recurrence rates after tumor resection. Further more, several case reports dealing with symptomatic me ningiomas during pregnancy have been published. 3, 26 In the presented case, the patient experienced minor symp toms despite the extent of the intracranial mass. The ad vanced pregnancy and concomitant low risk in delivering the fetus just days before reaching full term facilitated the decisionmaking toward cesarean delivery. Postpartum, meningioma shrinkage after pregnancy the lowdose steroids could be tapered until the resection, resulting in elective surgery under controlled conditions for the patient, her family, and the treating physicians. Contrastenhanced MRI was conducted just after deliv ery because there is a general recommendation against the use of Gd in pregnant women. A potential risk especially for the unborn includes nephrogenic systemic fibrosis be cause of immature renal function. Furthermore, Gd reten tion in the tissue with less stable agents and the lack of knowledge regarding its longterm effects are causes for concern, restricting use in neonates. 29 The same precau tion seems reasonable in pregnant women. This compels postponement of elective surgery in patients with minor symptoms until after the first vulnerable postpartum months, which provides the opportunity for the augment ed risks of thromboembolic events such as pulmonary em bolism, deep vein thrombosis, or coagulopathy disorders after birth to become normal. 12, 24 Furthermore, emotional components such as postpartum depression that could be aggravated after brain surgery may stabilize, leading to a better outcome. It seems reasonable to perform inter disciplinary risk assessments in patients presenting earlier in pregnancy and with symptomatic meningiomas, taking into account possible harm to the unborn and permanent neurological deficits.
5 Depending on the severity of symp toms and a potential trial of steroids, surgery may often still be indicated.
In cases with minor symptoms and relief with lowdose steroids following cesarean section, this strategy of de layed elective surgery might be the right choice for women at the end of a pregnancy. Elective surgery postponed for some months if possible leads to a stabilized situation and may also facilitate resection due to a reduced tumor size in meningiomas highly sensitive to levels of sex hormones.
RU486, a progesterone receptor antagonist, has been tested in clinical trials with mixed results. Grunberg et al. treated 14 patients, 5 of whom had an objective response and 3 of whom also experienced subjective improve ment. 13, 15 In a later series, the same group of investigators described 28 patients treated with the same drug, with a minor response in only 8 patients (all premenopausal).
14 Immunohistochemical testing was not performed. A re cent publication showed favorable results in postmeno pausal patients with multiple meningiomas with up to 10 years of followup. 27 Overall, the side effects of longterm RU486 treatment seem to be minor, so no discontinua tion of treatment was necessary in either study. Immuno histochemical progesterone receptor staining was done, although there was no proof of progesterone receptor expression; such staining seems to be mandatory when considering RU486 treatment. Both of the latter studies showed promising results in patients with a high proges terone receptor density in tumor tissue.
conclusions
Meningiomas can be influenced by levels of female sex hormones, leading to accelerated growth during pregnan cy. If possible and in cases of only minor symptoms, resec tion should be conducted after delivery. To our knowledge, the presented case shows, for the first time, that delaying surgery for some months after delivery may result in easier resection given the possible shrinkage of hormone sensitive meningiomas. In addition, a stabilized condition after pregnancy may be beneficial for those patients. 
